NCT04521023 - A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

September 20, 2017

Primary Completion Date

January 28, 2020

Study Completion Date

June 3, 2020

Conditions

Hypertension

Interventions

DRUG

Cantabell Tab

Patients assigned to experimental group are treated with Cantabell Tab

DRUG

Candemore Plus Tab

Patients assigned to experimental group are treated with Candemore Plus Tab

Trial Locations (14)

Ajou University Hospital, Suwon

Hallym Univ. Medical Center, Anyang

Daegu Catholic Univ. Medical Center, Daegu

MYONGJI Hospital, Goyang-si

Inje University Ilsan Paik Hospital, Ilsan-gu

Gachon University Gil Medical Center, Incheon

Jeju National University Hospital, Jeju City

Gangnam Severance Hospital, Seoul

Hallym University Kangnam Sacred Heart Hospital, Seoul

Hanyang University Medical Center, Seoul

Kangbuk Samsung Hospital, Seoul

SNU Boramae Medical Center, Seoul

Ulsan University Hospital, Ulsan

Wonju Severance Christian Hospital, Wŏnju